|
tocilizumab 162 mg / 0.9 mL (INJECTION)
|
$148.5649
|
|
AUS PBS
|
generic
|
| Actemra Subcutaneous Injection (4) |
Roche Products Pty Ltd |
| Actemra ACTPen (4) |
Roche Products Pty Ltd |
|
|
tocilizumab 180 mg / 1 mL (1 mL INJECTION)
|
$755.7500
|
|
VA Big4
|
|
| Actemra (1) |
Genentech USA |
|
|
tocilizumab 180 mg / 1 mL (1 mL INJECTION)
|
$770.7400
|
|
VA Big4
|
|
| Actemra ACTPen (1) |
Genentech USA |
|
|
tocilizumab 180 mg / 1 mL (1 mL INJECTION)
|
$999.9800
|
|
VA FSS
|
|
| Actemra ACTPen (1) |
Genentech USA |
|
|
tocilizumab 180 mg / 1 mL (1 mL INJECTION)
|
$1002.5200
|
|
VA FSS
|
|
| Actemra (1) |
Genentech USA |
|
|
tocilizumab 200 mg / 10 mL (INJECTION)
|
$157.9519
|
|
AUS PBS
|
generic
|
| Actemra (1) |
Roche Products Pty Ltd |
|
|
tocilizumab 20 mg / 1 mL (1 mL INJECTION)
|
$75.3205
|
|
VA Big4
|
|
| ACTEMRA (20) |
Genentech USA |
|
|
tocilizumab 20 mg / 1 mL (1 mL INJECTION)
|
$77.0350
|
|
VA Big4
|
|
| ACTEMRA (4) |
Genentech USA |
|
|
tocilizumab 20 mg / 1 mL (1 mL INJECTION)
|
$79.0210
|
|
VA Big4
|
|
| ACTEMRA (10) |
Genentech USA |
|
|
tocilizumab 20 mg / 1 mL (1 mL INJECTION)
|
$106.0840
|
|
VA FSS
|
|
| ACTEMRA (20) |
Genentech USA |
|
|
tocilizumab 20 mg / 1 mL (1 mL INJECTION)
|
$106.0850
|
|
VA FSS
|
|
| ACTEMRA (4) |
Genentech USA |
| ACTEMRA (10) |
Genentech USA |
|
|
tocilizumab 400 mg / 20 mL (INJECTION)
|
$314.2989
|
|
AUS PBS
|
generic
|
| Actemra (1) |
Roche Products Pty Ltd |
|
|
tocilizumab 80 mg / 4 mL (INJECTION)
|
$63.7219
|
|
AUS PBS
|
generic
|
| Actemra (1) |
Roche Products Pty Ltd |
|
